CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis

Author:

Jin An‐Li1,Zhang Chun‐Yan12,Zheng Wen‐Jing34,Xian Jing‐Rong1,Yang Wen‐Jing1,Liu Te15,Chen Wei1,Li Tong1,Wang Bei‐Li126ORCID,Pan Bai‐Shen16,Li Qian16,Cheng Jian‐Wen3,Wang Peng‐Xiang3,Hu Bo3,Zhou Jian3,Fan Jia3,Yang Xin‐Rong3ORCID,Guo Wei1726ORCID

Affiliation:

1. Department of Laboratory Medicine Zhongshan Hospital Fudan University Shanghai P. R. China

2. Department of Laboratory Medicine Xiamen Branch Zhongshan Hospital Fudan University Xiamen P. R. China

3. Department of Liver Surgery & Transplantation Liver Cancer Institute Zhongshan Hospital Fudan University Key Laboratory of Carcinogenesis and Cancer Invasion Ministry of Education Shanghai P. R. China

4. Department of Hepatobiliary Surgery Shenzhen Key Laboratory Guangdong Provincial Key Laboratory of Regional Immunity and Diseases International Cancer Center Shenzhen University General Hospital Shenzhen University Clinical Medical Academy Shenzhen University Shenzhen Guangdong P.R. China

5. Shanghai Geriatric Institute of Chinese Medicine Shanghai University of Traditional Chinese Medicine Shanghai P. R. China

6. Department of Laboratory Medicine Wusong Branch Zhongshan Hospital Fudan University Shanghai P. R. China

7. Cancer Center Zhongshan Hospital Fudan University Shanghai P. R. China

Funder

National Natural Science Foundation of China

Sanming Project of Medicine in Shenzhen

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3